Free Trial
→ Trump’s betrayal exposed (From Porter & Company) (Ad) Buy BDRX Stock  Free BDRX Stock Alerts

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$1.59 -0.16 (-9.14%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$1.63 +0.04 (+2.52%)
As of 07:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Biodexa Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
03/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
3:30 PM		Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
02/13/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/22/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:27 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:30 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:21 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:24 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/17/2025
3:49 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/17/2025
3:21 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
12/27/2024
4:15 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:56 AM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
Trump’s Great Society (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/19/2024
3:30 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/30/2024
3:38 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
08/20/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/12/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/08/2024
3:24 PM		Biodexa Pharmaceuticals (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SC 13G
08/01/2024
2:37 PM		Biodexa Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
07/23/2024
2:09 PM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G
07/23/2024
7:55 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
8:34 AM		Biodexa Pharmaceuticals (Filer)
Form 424B5
07/19/2024
12:00 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K/A
07/19/2024
8:03 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
7:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
Trump’s Final Plan (Ad)

Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.

Click here for the full story.
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/05/2024
4:24 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
7:44 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/17/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/13/2024
8:48 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BDRX) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners
Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...
Porter & Company | Sponsored
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...
Paradigm Press | Sponsored
DOGE could send 6 AI stocks through the roof
Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...
Weiss Ratings | Sponsored
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...
American Alternative | Sponsored
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...
Brownstone Research | Sponsored
Here’s Why Tesla Insiders are Dumping Shares
Tesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...
Behind the Markets | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...
Crypto 101 Media | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored